Home/Specialties/Dermatological & Mohs Surgery

Practice · Dermatological & Mohs Surgery

The Mohs referral engine your derm-surgery suite has been waiting for.

We build dermatologist, GP and oncology referral pathways for Mohs micrographic surgery and complex dermatologic reconstruction — measured in scheduled Mohs stages and reconstructive follow-ups.

For Chiefs of Dermatology, Mohs Surgeons and MDs of super-specialties with dedicated dermatologic-surgery programmes.

Request a Derm & Mohs Pipeline Blueprint →Review case evidence

Mohs Case Volume

+218%

12-month cohort

Dermatologist MOUs

signed in metro catchment

Recon Continuity Rate

88%

post-Mohs → reconstruction

OT Utilization

74%

derm-surgery suite

Procedure-level demand engineering

We target the procedures that move your P&L, not the ones that fill the OPD queue.

CATCHMENT TIER · PRICE RESTATEMENT

ARPU differs materially between Metro, Tier-2 and Tier-3 catchments. Switch tier to restate every procedure band against the payer mix and package ceilings we observe in that market — not a single all-India number.

Viewing Metro / Tier-1 · Representative catchments: Delhi NCR, Mumbai, Bengaluru, Chennai, Hyderabad, Kolkata, Pune.

Mohs Micrographic Surgery

₹1.4 L–3.5 L

Dermatologist-referred skin CA funnel

Post-Mohs Reconstruction

₹80K–2.4 L

Continuity-of-care follow-up

Complex Skin CA Excision

₹1.2 L–3.2 L

Second-opinion referral funnel

Vitiligo & Depigmentation Surgery

₹40K–1.4 L

Long-cycle chronic-disease funnel

Hair Restoration (FUE/DHI)

₹80K–2.4 L

Ethically-marketed elective funnel

Scar Reconstruction

₹60K–1.8 L

Post-trauma & post-surgical referral

Methodology. Base bands reflect RDV's engagement dataset across 47 super-specialty hospitals, reconciled against CGHS/ECHS package rates, state-scheme ceilings (Ayushman Bharat PM-JAY, CMCHIS, YSR Aarogyasri) and empanelled TPA grids. Tier multipliers applied: Metro 1.00× · Tier-2 0.72× · Tier-3 0.55×. Actuals swing with payer mix, consultant-fee split and implant/consumable choice — the written Blueprint restates every band against your own HIS billing history before any spend is committed.

Clinical referral pathway

Intent → triage → consult → admission. Instrumented at every gate.

01 · Intent capture
Symptom, condition and referrer-based intent capture across catchment.
02 · Clinical triage
Specialty-trained nurse/coordinator triage with report upload before consult.
03 · Consultant handoff
Calendar-synced booking to the operating consultant with pre-read notes.
04 · Admission & OT slotting
CRM ↔ HIS tag: admission source, procedure code, OT date.

Case snapshot

3.1× Mohs case volume, 88% reconstruction continuity.

A representative RDV engagement in the Dermatological & Mohs Surgery practice line. Individual results vary by catchment, clinical capacity and payer mix.

Setting: Dermatologic surgery unit inside tertiary, 20 beds
Duration: 12 months
Cohort: n = 420 dermatologist-referred cases
Outcome: 3.1× Mohs case volume, 88% reconstruction continuity

Figures engagement-verified against hospital HIS. No outcome guarantees implied; per NMC advertising guidelines.

Why Chiefs of Derm & Mohs choose RDV

Trust is earned in the operating logic, not the pitch deck.

Dermatologist referrer primacy

Mohs volume flows exclusively through dermatologist referrals. Signed MOU network is the primary demand engine.

Continuity-of-care design

Every Mohs patient enters a documented reconstruction pathway. Continuity is both a clinical asset and a revenue asset.

Cure-rate honesty

Mohs is 95%+ curative for most BCC/SCC — we say so with the caveat, not the marketing exaggeration.

Hair-restoration ethics

Elective hair work uses consented process content, realistic outcome framing and no coercive financing tactics.

From an engagement

"The dermatologist MOU programme is why our Mohs suite is booked 3 weeks out. Continuity from Mohs to reconstruction became the compounding asset."

— Chief of Dermatologic Surgery · 20-bed tertiary unit

Attribution anonymised per client confidentiality; engagement code verifiable in the founder-led review.

Talk directly to the founding partner who ran this engagement.

Request a Derm & Mohs Blueprint →

48-hour founder-led review. Fixed-scope. No lock-in.

Clinical authority

Content your clinicians will co-sign.

Mohs surgeon stage-by-stage explainer library
Dermatology + Mohs + plastics tri-disciplinary MDT
Post-Mohs reconstruction outcome registry

Compliance posture

Every asset, every claim, medically reviewed.

NMC norms — no cure-rate percentages in skin CA content
Consent-first clinical imagery workflow
Hair-restoration outcome-neutral communication mandatory

Catchment note: Metropolitan dermatologist-network engineering; senior-cohort catchments for skin cancer awareness.

The 21-day diagnostic

What the fixed-scope engagement actually contains — for Derm & Mohs.

No mystery, no scope creep. Each week is instrumented and delivered against a checklist your MD and Chief signs.

Week 1
Derm-surgery suite audit; Mohs vs excision case-mix baseline.
Week 2
Dermatologist, GP and oncology referrer mapping.
Week 3
Procedure economics; Mohs-to-reconstruction continuity revenue model.
Week 4
Founder-led blueprint with Chief of Dermatologic Surgery.

Where we compound

The unfair edge — for Derm & Mohs specifically.

Dermatologist MOU network at 40+ signed practices per metro
Post-Mohs reconstruction continuity rate near category ceiling
Hair-restoration ethics framework — differentiator vs commodity clinics

Practice guarantees

What we commit to in writing.

Fixed-scope diagnostic — no retainer, no annual lock-in
HIS-verified attribution — every claimed admission traceable to source
No media markup — you see raw platform invoices at cost
Founder-led — the partner who scopes the engagement does the work

Objections we hear

The three questions MDs ask before signing.

We keep our answers on the record. If yours isn't here, ask it in the qualification form — the founding partner replies personally within 48 hours.

Mohs isn't a consumer-marketing category.

Correct — it's a dermatologist-referrer category. That's exactly our engagement.

Hair restoration is a race to the bottom.

Which is why we don't compete on price. We compete on documented outcomes and ethical framing. Different segment, protected margin.

Our post-Mohs reconstruction goes to external plastics.

Then we structure an in-house tri-disciplinary MDT so it doesn't. Continuity revenue is the largest missed opportunity in derm-surgery.

FAQ

The questions Chiefs of Derm & Mohs ask us first.

If yours isn't here, put it in the qualification form — our founding partner will answer it in the 48-hour review.

How do you build dermatologist MOU networks?+

District by district with a documented value exchange: shared MDT slots, joint patient education and post-Mohs outcome sharing back to the referring dermatologist.

Can hair restoration be marketed ethically?+

Yes — with consented process content, transparent graft-count and density expectations, and no coercive financing. Compounds referrals over 12–18 months.

What about vitiligo surgery?+

A long-cycle chronic-disease funnel. Volume follows dermatologist trust and patient-community credibility built over years, not months.

Next step